Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,122 total articles

MODIV INDUSTRIAL CEO Executives Buy $62,163 Worth of Company Stock

MODIV INDUSTRIAL CEO Executives Buy $62,163 Worth of Company Stock

Aaron Scott Halfacre, Chief Executive Officer and President of MODIV INDUSTRIAL, INC. (NASDAQ:MDV), executed a direct purchase of company equity totaling $62,163 on June 30, 2026. This transaction involved the acquisition of 3,585.74 shares of Class C common stock, with prices ranging from $17.21 to $17.55 per share. The purchase increases Halfacre…

Simon Property Group Director Stefan Selig Purchases $49,119 in Company Shares Amid Mixed Analyst Outlook

Simon Property Group Director Stefan Selig Purchases $49,119 in Company Shares Amid Mixed Analyst Outlook

Stefan M. Selig, a director at Simon Property Group Inc. (NYSE:SPG), has acquired company stock totaling $49,119 through multiple transactions on June 30, 2026. The purchases were executed via the reinvestment of dividends from restricted stock awards, bringing his direct holdings to 33,812 shares. This insider activity coincides with SPG's recent …

Simon Property Director Peggy Roe Acquires $19,860 in SPG Stock

Simon Property Director Peggy Roe Acquires $19,860 in SPG Stock

Director Peggy Roe of Simon Property Group Inc. (NYSE: SPG) completed a $19,860 acquisition of company shares on June 30, 2026. The transaction occurred as SPG trades near its 52-week high of $228.57, following a 42.6% return over the past year. The purchase includes 80 shares from dividend reinvestment and additional shares acquired on the same da…

Nuvectis Pharma Insider Transaction and Capital Raise Analysis

Nuvectis Pharma Insider Transaction and Capital Raise Analysis

Marlio Charles Mosseri, a 10% owner of Nuvectis Pharma, Inc. (NASDAQ:NVCT), acquired 50,000 shares of common stock for a total value of $916,000 on June 30, 2026. The acquisition was made indirectly through Emerald Hill Ventures SARL SPF, an entity for which Mr. Mosseri is the beneficial owner. Following this transaction, Mr. Mosseri beneficially o…